NCT04266886

Brief Summary

This trial studies how well self-hypnosis works in enhancing recovery after surgery in patients with gynecologic cancer. A guided relaxation method called self-hypnosis may help affect how patients feel pain and symptoms after surgery.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2018Dec 2027

Study Start

First participant enrolled

September 11, 2018

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 30, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 12, 2020

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

9.3 years

First QC Date

December 30, 2019

Last Update Submit

March 11, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility of participating in pre-operative self-hypnosis

    Will assess proportion of participants who listen to the complete audio file in the preoperative holding area.

    Up to 1 day

  • Patients' perception of post-surgical pain

    Will summarize POD1 pain scores for each treatment arm using descriptive statistics. Will use a Wilcoxon rank sums test to determine if the POD1 pain scores in the self-hypnosis arm are lower than the usual care arm. Pain intensity score from 0 to 10.

    Post-operative day 1 (POD1)

Study Arms (2)

Arm I (usual care)

ACTIVE COMPARATOR

Patients receive usual care including receipt of multi-modal analgesia and the injection of a local analgesic at the time of surgery on the ERAS pathway.

Other: Best PracticeOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Arm II (usual care, self-hypnosis guided relaxation)

EXPERIMENTAL

Patients receive usual care as in Arm I. Patients also receive self-hypnosis guided relaxation by listening to MP3 on the ERAS pathway.

Other: Best PracticeProcedure: HypnotherapyOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Receive usual care

Also known as: standard of care, standard therapy
Arm I (usual care)Arm II (usual care, self-hypnosis guided relaxation)
HypnotherapyPROCEDURE

Receive self-hypnosis guided relaxation

Also known as: Clinical Hypnosis, Hypnosis
Arm II (usual care, self-hypnosis guided relaxation)

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (usual care)Arm II (usual care, self-hypnosis guided relaxation)

Ancillary studies

Arm I (usual care)Arm II (usual care, self-hypnosis guided relaxation)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing an exploratory laparotomy for suspected gynecologic cancer, which includes metastatic disease from neoplasia originating in other organs
  • Planned participation in the Gynecologic Enhanced Recovery Pathway
  • Patient must be able to read, understand, and speak English
  • Consents to being part of a randomized study
  • Patient has physical and mental capabilities to take part in study

You may not qualify if:

  • Sensitivity to amide-type local anesthetics
  • Patients on long-acting opioid medications, or scheduled (four or more times a day for seven or more days) short-acting opioid medications within the last 30 days
  • Emergency surgery of any type that does not allow for proper time for protocol review by the patient
  • Surgery that involves known/anticipated resection of anterior abdominal wall with plastic surgery reconstruction
  • Patients undergoing known/anticipated anterior abdominal wall hernia repairs
  • Patients undergoing pelvic exenteration
  • Patients with known major psychiatric disease
  • Patients with hearing impairment such that they are unable to hear the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Interventions

Practice Guidelines as TopicStandard of CareHypnosis

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Guidelines as TopicQuality Assurance, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationQuality Indicators, Health CareMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Larissa A Meyer

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2019

First Posted

February 12, 2020

Study Start

September 11, 2018

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations